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been linked to the suppression of calcineurin-nuclear factor of activated T cells signaling by RCAN1.
Here, we describe a novel role of RCAN1 isoform 4 in proper expression of Ras protein and its signal-
ing. RCAN1 isoform 4 knockdown attenuated growth factor-induced extracellular signal-regulated
kinase activation and cell growth; reduced Ras levels and its translation rate; and led to a reduction
of eukaryotic initiation factor 4E in the initiation complex and a slight repression of global protein
synthesis. Experiments utilizing activity-modiﬁed mutants of calcineurin A demonstrated that these
effects were calcineurin-independent. Our ﬁndings reveal a previously unknown role of RCAN1-4 in
protein synthesis, which may be relevant to cell growth.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The human regulator of calcineurin 1 (RCAN1) gene, also
termed Down syndrome candidate region 1, was ﬁrst isolated near
the portion of the Down Syndrome Critical Region on chromosome
21 [1]. The gene consists of seven exons; exons 1–4 can be alterna-
tively spliced, resulting in four different transcripts denoted as
RCAN1-1 through RCAN1-4. RCAN1 protein binds to the catalytic
subunit of a Ca2+/calmodulin-dependent phosphatase calcineurin
and inhibits its function [2]. Elevated RCAN1 expression has been
observed in neurodegenerative diseases, including Alzheimer’s dis-
ease and Down syndrome [3], in the heart after pressure-overload
[4], and in the peri-infarct cortex following experimental stroke
[5].
Altered RCAN1 expression exerts diverse inﬂuences on cell pro-
liferation. Over-expression of hamster homologue adapt78 induces
G1-phase growth arrest in hemagglutinin (HA)-1 cells [6]. Consis-
tently, adenovirus-mediated introduction of RCAN1-4 into endo-chemical Societies. Published by E
1; NFAT, nuclear factor of
d kinase; eIF4E, eukaryotic
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f Pharmacology, College of
g 505, Seocho-gu, Seoul 137-thelial cells induces G0/G1 arrest and inhibits angiogenesis [7].
On the other hand, the over-expression of RCAN1-1 promotes the
proliferation of PC-12 cells [8]. In a study addressing isoform-spe-
ciﬁc functions, over-expression of RCAN1-1 induced endothelial
cell proliferation, but RCAN1-1-speciﬁc knockdown did not affect
the baseline cell growth. On the other hand, over-expression of
RCAN1-4 did not affect baseline endothelial cell growth, and
RCAN1-4-speciﬁc knockdown enhanced cell proliferation [9].
These observations suggest that RCAN1 may play differential roles
in cell growth, dependent on cell types and isoforms of RCAN1. Un-
til now, the speculated role of RCAN1 in cell growth has been
mainly based on its function as a negative regulator of calcineurin
signaling. Hence, the effects on growth-related signal transduction
molecules have not been elucidated in detail.
Here, we investigated the effects of altered RCAN1-4 expression
on cell proliferation and growth factor-induced activation of extra-
cellular signal-regulated kinase (ERK) pathway.2. Materials and methods
2.1. Cell culture
Human U87MG glioblastoma cells and human 293T embryonic
kidney cancer cells were obtained from American Type Culture
Collection (Manassas, VA). The cells were maintained in minimallsevier B.V. All rights reserved.
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(293T) supplemented with 1.0 mM sodium pyruvate and 10% fetal
bovine serum under an atmosphere of 5% CO2 at 37 C. If needed,
the cell number was counted using a Z2 Coulter Counter (Multisiz-
er II, Beckman–Coulter).
2.2. Biochemical procedures
Chemicals and antibodies, plasmid construction, short interfer-
ing RNA (siRNA)-mediated RNA interference, metabolic cell label-
ing and immunoprecipitation, pulse-chase analysis, pull-down
assays, luciferase assay, Triton X- 114 separation, real-time quanti-
tative RT-PCR analysis, and immunoblot analysis were performed
according to standard protocols. Details can be found in the Sup-
plementary data.3. Results
3.1. RCAN1-4 knockdown suppresses U87MG cell growth
We compared the growth rate of U87MG cells with RCAN1-4
knocked down and control cells. To suppress the expression of
endogenous RCAN1-4, we designed siRNA targeted against exon
4 (siRCAN1-4). Transfection with this siRNA resulted in an approx-
imate 90% reduction in mRNA levels, which were quantiﬁed by
real-time RT-PCR analysis (Fig. 1A). After transfection with siR-
CAN1-4 or control siRNA, the number of cells in culture was
counted every 24 h until 96 h. The cell numbers for siRCAN1-4-
transfected and control cultures were not signiﬁcantly different
24 and 48 h after the transfection. However, at 72 h and 96 h, the
growth of siRCAN1-4-transfected cells was signiﬁcantly retarded
relative to control cells (29% and 35%, respectively; Fig. 1B). Earlier
reports demonstrated the arrest of cell cycle progression in RCAN1-
modulated cells [6,7]. To investigate the involvement of cyclin-
dependent kinase inhibitors in the retardation of cell growth, we
examined the level of p21 and p27Kip1. As shown in Fig. 1C, siR-
CAN1-4 signiﬁcantly increased p21 and p27 Kip1 expression in a
time-dependent manner.Fig. 1. RCAN1 knockdown suppresses U87MG cell growth. (A) Real-time PCR for
RCAN1-4 (left) and detection of RCAN1-4 expression (right) in U87MG cells
transfected with either siRCAN1-4 or siCon. (B) U87MG cells were transfected with
either a speciﬁc siRNA for RCAN1 isoform 4 (siRCAN1-4) or control siRNA (siCon),
and cell growth was determined by a Coulter counter. Results are the means and
S.D. of three independent experiments (*P < 0.05, **P < 0.001 versus time-matched
control). (C) Representative immunoblot showing the time-dependent change of
p21 and p27Kip1 expressions following transfection with either siRCAN1-4 or
siCon.3.2. RCAN1-4 knockdown attenuates the growth factor-induced ERK
activation
Next, we examined ERK activation in response to growth fac-
tors. Compared with controls, siRCAN1-4-transfected cells exhib-
ited an attenuated induction of ERK phosphorylation following
bFGF treatment (Fig. 2A). Attenuated ERK phosphorylation was
also observed in response to phorbol 12-myristate 13-acetate
and calcium ionophore A23187 stimulation (data not shown). We
examined the activation of the upstream ERK signal to identify a
target molecule that is directly inhibited by RCAN1-4 knockdown.
Transfection with siRCAN1-4 attenuated the EGF-induced phos-
phorylation of Raf-1 and MEK (Fig. 2B). Notably, the level of Ras
protein was also reduced in siRCAN1-4-transfected cells relative
to controls. Transcription of the reporter gene mediated by Elk-1,
a downstream effector molecule of ERK, was also reduced in siR-
CAN1-4-transfected cells (Fig. 2C). Reciprocally, vector-mediated
over-expression of green ﬂuorescent protein (GFP)-RCAN1-4 par-
tially rescued the attenuated phosphorylation of ERK in siRCAN1-
4-transfected cells (Fig. 2D).3.3. RCAN1-4 knockdown reduces steady-state levels of Ras protein
Based on the reduction of Ras expression, we hypothesized
that the attenuated response of the ERK pathway to growth fac-tors resulted from a deﬁcit of Ras-mediated signal transduction.
We examined Ras activation following the stimulation of EGF.
As expected, the amount of GTP-bound Ras in siRCAN1-4-trans-
fected cells was signiﬁcantly low compared to control (by 42%
and 31% at 10 min and 30 min after stimulation, respectively;
Fig. 3A). We then investigated whether there is a change in the
synthesis of Ras and its post-translational prenylation, which is
important for Ras protein localization to the plasma membrane
and receiving signals from receptors [10]. The cytosolic and
membrane-bound forms of Ras were separated by Triton X-114
and quantiﬁed by Western blot analysis [11]. Prenylated Ras pro-
tein in detergent phase was reduced by 47% in siRCAN1-4-trans-
fected cells compared to control (Fig. 3B). A longer exposure of
Fig. 2. RCAN1-4 knockdown attenuates growth factor-induced ERK activation. (A) Time course study showing bFGF (10 ng/ml)-induced ERK phosphorylation (top) in U87MG
cells transfected with either siRCAN1-4 or siCon. Densitometric ratios of the p-ERK/ERK signal (bottom) are represented as mean and S.D. from three independent
immunoblots (*P < 0.05 versus time-matched control). (B) Immunoblot showing EGF (20 ng/ml for 10 min) induced phosphorylation of signaling molecules in an upstream
ERK pathway of 293T cells. (C) Attenuation of Elk-1 promoter-driven luciferase expression following EGF treatment (20 ng/ml for 4 h) in siRCAN1-4-transfected 293T cells.
Results are the means and S.D. of four independent experiments. *P < 0.05 compared with siCon. (D) Immunoblot of EGF (20 ng/ml for 10 min) induced phosphorylation of
ERK in 293T cells co-transfected with either a vector encoding RCAN1-4 (GFP-RCAN1) or GFP, and either siRCAN1-4 or siCon in the combinations indicated.
H.J. Lee et al. / FEBS Letters 583 (2009) 2557–2564 2559the same panel showed that non-prenylated Ras in aqueous
phase was also reduced by 45%. These observations suggest that
siRCAN1-4 down-regulates the overall level of Ras protein
expression rather than a post-translational maturation process.
Consistent with the ERK response to EGF (Fig. 2C), over-expres-
sion of GFP-RCAN1-4 partially rescued Ras expression (Fig. 3C).
We next examined an isoform-speciﬁc effect of RCAN1. Cells
were transfected with siRCAN1-4 and siRCAN1-1 speciﬁcally tar-
geted to exon1. Transfection of siRCAN1-1 inhibited Ras expres-
sion by 17% (Fig. 3D). Interestingly, transfection of siRCAN1-1
increased the transcription of endogenous RCAN1-4 by twofold
(data not shown). The transcription of RCAN1-4 gene is activated
potently by calcineurin due to the presence of multiple consen-
sus nuclear factor of activated T cells (NFAT) binding sites within
an internal promoter region [12]. Thus this increase of RCAN1-4
transcript is probably due to the release of calcineurin from an
inhibitory effect of RCAN1-1. In the next experiments, we used
only RCAN1-4.3.4. RCAN1-4 knockdown does not affect Ras transcription and protein
stability
The cellular protein level is the net result of protein synthesis
and degradation. To explore the molecular basis of the reduction
in Ras expression, we ﬁrst examined transcriptional level of Ras
isoforms. Real-time PCR analysis revealed that H- and K-Ras mRNA
levels were not signiﬁcantly decreased, and N-Ras transcription
was rather increased in siRCAN1-4-transfected cells (Fig. 4A).
These results suggest that reduced expression of Ras protein was
not due to suppression in transcriptional stage. To investigate the
stability of Ras protein, we next examined whether it is actively de-
graded by various cellular proteases. siRCAN1-4-transfected or
control cells were treated for 8 h with the proteasomal inhibitor
MG132 and the lysosomotrophic agent chloroquine. The cells were
then subjected to immunoblot analysis for Ras. Inhibition of these
proteases did not block the reduction of Ras expression in siR-
CAN1-4-transfected cells (Fig. 4B). To conﬁrm that siRCAN1-4 does
Fig. 3. RCAN1-4 knockdown reduces the steady-state level of Ras protein. (A) Time course study showing the formation of GTP-bound Ras (GTP-Ras) after EGF treatment
(20 ng/ml) to 293T cells transfected with indicated siRNA, which was assayed by pull-down (PD) with glutathione S-transferase-RBD. (B) Immunoblot showing the attenuated
expression of prenylated (upper bands) and non-prenylated Ras (lower bands) in siRCAN1-4-transfected 293T cells. a, aqueous phase; d, Triton X-114 detergent phase
containing lipid-associated proteins. The relative density of bands was given below. The value obtained in siCon-transfected cells were set as 100% (C) Immunoblot showing
that co-transfection of GFP-RCAN1-4 increases Ras expression in 293T cells transfected with siRCAN1-4. (D) Immunoblot showing effects of isoform-speciﬁc siRCAN1s on Ras
expression in U87MG cells.
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sis for Ras degradation. The cells were pulsed with [35S]-methio-
nine/cysteine for 4 h and then chased for 20 h. Quantitative
analysis of the remaining radiolabeled Ras revealed that the degra-
dation rates of Ras protein were not signiﬁcantly different between
the siRCAN1-4-transfected cells and controls (Fig. 4C). Collectively,
these results indicate that the reduction in Ras expression is not
due to enhanced protein degradation or attenuated transcription.
3.5. RCAN1-4 knockdown decreases Ras protein translation
We next examined the translational efﬁciency of Ras protein.
The cells were cultured in a medium containing [35S]-methio-
nine/cysteine to radiolabel the newly synthesized proteins for
two time periods: 30 and 60 min. After the indicated incubation,
cell lysates were obtained and analyzed by SDS–PAGE. Quantita-
tive imaging with a phosphorimager demonstrated that newly syn-
thesized Ras in siRCAN1-4-transfected cells was 64.6% and 74% less
than that of time-matched controls at 30 and 60 min, respectively
(Fig. 5A). Overall, 35S-labeled cellular protein was also reduced in
RCAN1-4-transfected cells by about 20% relative to control cells
(Fig. 5B). It is notable that Ras synthesis is more intensively inhib-
ited than global translation. These observations suggest a role for
RCAN1-4 in translational regulation. The eukaryotic initiation fac-
tors eIF4E, eIF4G, and eIF4A comprise the trimeric eIF4F complex,
which promotes cap-dependent mRNA translation [13]. Therefore,
we tested whether RCAN1-4 knockdown alters the expression of
eIFs or assembly of the eIF4F complex. Transfection with siR-
CAN1-4 had no measurable effect on the levels of eIF4A and eIF4G
proteins but resulted in reduced eIF4E and eIF4E-binding protein(eIF4E-BP1) levels. To determine whether these alterations could
disrupt the eIF4E complex, we examined the association of eIFs
by pulling down with m7GTP-sepharose resin. The precipitation as-
say showed a reduced association of eIF4E and eIF4E-BP1, whereas
the amounts of eIF4A and eIF4G were not signiﬁcantly altered
(Fig. 5C). These ﬁndings suggest an inhibitory role for RCAN1-4
in the translation initiation processes, probably by down-regulat-
ing eIF4E.
3.6. siRCAN1-4 inhibits translation by a calcineurin-independent
mechanism
RCAN1 is an endogenous inhibitor of calcineurin, and targeted
deletion or knockdown of this gene results in the activation of cal-
cineurin [9,14]. We next examined whether the elevated calcineu-
rin activity in siRCAN1-4-transfected cells contributes to the
attenuated translation of Ras protein. We knocked down either cal-
cineurin Aa (siCnAa) or calcineurin Ab (siCnAb) simultaneously
with RCAN1-4. Reducing the abundance of calcineurin did not res-
cue Ras expression in siRCAN1-4-transfected cells (Fig. 6A). Simi-
larly, pharmacological inhibitors of calcineurin, cyclosporine A
and FK506, did not restore the attenuated ERK response to bFGF
(Fig. 6B). We then investigated whether the translation deﬁcit in
siRCAN1-4-transfected cells was also independent of calcineurin.
We examined the translational efﬁciency in siCnA-transfected cells
and siRCAN1-4-transfected cells by monitoring vector-mediated
expression of GFP as a reporter [15,16]. The GFP expression vector
was transfected 24 h after siRNA transfection, and cells were incu-
bated another 24 h before immunoblot analysis. Consistent with
the results of a metabolic labeling experiment for the analysis of
Fig. 4. RCAN1-4 knockdown does not affect Ras transcription and protein stability.
(A) Effects of siRCAN1-4 on the Ras transcript levels of 293T cells measured by real-
time RT-PCR. *P < 0.05 compared with siCon. (B) Immunoblot showing that a
proteasome inhibitor (MG132; 4 lM for 8 h) or lysosome inhibitor (chloroquine;
200 lV for 8 h) does not block the siRCAN1-4-induced reduction of Ras in U87MG
cells. (C) Degradation of Ras protein. U87MG cells were pulsed with [35S]-
methionine/cysteine for 4 h. Radiolabeled Ras was chased for 20 h.
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inhibited the expression of GFP (Fig. 6C). Interestingly, the siCnAs
also inhibited GFP expression instead of an expected opposite ef-
fect to that of siRCAN1-4 (Fig. 6D). Next, we assessed whether cal-
cineurin activation enhanced Ras and GFP expression. Transfection
of the constitutively active form of calcineurin increased Ras and
GFP expression by 10% and 32%, respectively, indicating a positive
role of calcineurin A in Ras and GFP translation (Fig. 6E). Taken to-
gether, these data suggest that siRCAN does not inhibit Ras trans-
lation by augmenting calcineurin signaling.
4. Discussion
The evidence that proper RCAN1 expression plays an important
role in proliferation has been observed in diverse cell type. RCAN1
is involved in proliferation as well as growth suppression [6–
9,14,17]. Furthermore, each RCAN1 isoform plays differential roles
in cell proliferation in response to a growth factor [9]. Thus, themechanism by which RCAN1 modulates cell proliferation is com-
plicated and not completely understood.
In contrast with the previous report utilizing vascular endothe-
lial cells [9], we demonstrated that RCAN1-4 knockdown results in
the retarded growth of U87MG cells and the attenuated activation
of the ERK pathway in response to growth factors. In addition, our
results showed for the ﬁrst time that RCAN1-4 knockdown sup-
pressed translation initiation complex formation and total protein
synthesis in a calcineurin-independent manner. This may affect
cell growth because many growth regulators are encoded by weak
mRNAs, translation of which is more sensitive to small perturba-
tions in translation initiation complex formation [13,18–20].
Among them, this study showed Ras protein as one of the signaling
molecules relevant to cell growth and sensitive to the defect of
translation induced by knockdown of RCAN1-4.
RCAN1-4 reportedly works as a negative regulator of cell
growth by inhibiting calcineurin/NFAT pathway-dependent mech-
anism [7,9]. Thus, RCAN1-4 knockdown can enhance cell growth
via a calcineurin-dependent mechanism [9], and can also suppress
cell growth via a calcineurin-independent mechanism, which is
suggested by this study. The dominance between these opposite
events may be affected by the temporal status and types of cells.
In addition to this, isoform-speciﬁc differential effects of RCAN1
on calcineurin may explain the diversity of growth responses to
RCAN1 modulation. In addition, the phosphorylation status of
RCAN1 is reported to affect calcineurin signaling [21]. Thus, the
overall effects of RCAN1 on growth would be extremely diverse
depending on the cellular context.
The independence of siRCAN1-4-induced down-regulation of
Ras on the calcineurin pathway was shown in several experiments
utilizing pharmacological inhibitors, siRNAs, and calcineurin A mu-
tants. Although a mechanism was not addressed in this study,
these experiments revealed that calcineurin is a positive regulator
of Ras translation in U87MG cells. Similarly, a requirement for cal-
cineurin in translational machinery activation has been reported in
rat pancreatic acini [22]. Given that RCAN1-4 is a negative regula-
tor of calcineurin, RCAN1-4 knockdown is expected to exert inﬂu-
ence on Ras expression into two modes: facilitation of translation
by activating a calcineurin-dependent mechanism and translation
inhibition via a calcineurin-independent mechanism.
The mechanism by which RCAN1-4 knockdown preferentially
inhibits the translation of Ras protein is not completely solved in
this study. In this respect, we showed that knocking down
RCAN1-4 reduced eIF4E expression and its binding to the 7-
methyl-GTP cap structure. In eukaryotes, roughly 90% of protein
is synthesized through cap-dependent translation. Indeed, knock-
ing down RCAN1-4 reduced global translation in U87MG cells. This
observation raised the question of why Ras expression was
strongly inhibited compared to that of other proteins observed in
this study. Cellular mRNAs differ hugely in the amount of eIF4F
complex required for efﬁcient translation [13]. The translation efﬁ-
ciency of mRNA with highly complex 50-untranslated regions (50-
UTR) is especially dependent on eIF4E levels [18]. Therefore, we
predicted the secondary structure of the 50-UTR of H-ras, K-Ras,
and N-Ras using the MFOLD program [23]. The sequences of H-
ras, K-Ras, and N-Ras 50-UTR were predicted to form several highly
structured stem loops (data not shown). Similarly, Kumari et al.
[24] reported that N-Ras contains a highly conserved, thermody-
namically stable RNA G-quadruplex in the native 50-UTR. Thus,
we speculate that an alteration in eIF4E expression might preferen-
tially affect the translationally weak Ras mRNA.
Another possible explanation for the preferential reduction of
Ras translation is that RCAN1 may be an mRNA binding protein.
A stretch of roughly 80 amino acids near the N-terminus of this
protein shows similarity with the RNA recognition motif, which
could exert nucleic acid-binding functions [25]. Whether RCAN1-
Fig. 5. RCAN1-4 knockdown decreases Ras translation. (A) Autoradiography (top) and densitometric (right) analysis showing newly synthesized Ras protein following [35S]-
methionine/cysteine labeling for the indicated periods from U87MG cells transfected with indicated siRNA. Coomassie blue staining of the SDS–PAGE gel as a loading control
(bottom). (B) Autoradiography (top) and densitometric (right) analysis showing overall protein synthesis. Coomassie blue staining of the SDS–PAGE gel as a loading control
(bottom). (C) Impaired assembly of the eIF4F complex in 293T cells transfected with siRCAN1-4. After pull-down, proteins eluted from m7GTP-sepharose 4B (upper) and
whole cell lysates (lower) were analyzed by immunoblot.
2562 H.J. Lee et al. / FEBS Letters 583 (2009) 2557–25644 binds with the mRNA of speciﬁc proteins and controls their
translation is unknown, but this possibility is currently under
investigation.
The biological signiﬁcance of cell growth control by RCAN1 has
been demonstrated in physiologic angiogenesis, tumor angiogene-sis, and its growth. Patients with Down syndrome have a different
risk and clinical prognosis of certain malignancies. The compli-
cated and diverse functions of RCAN1 on cell growth suggest that
a pathway-speciﬁc approach is needed to target this gene for anti-
angiogenic and anticancer therapy.
Fig. 6. siRCAN1-4 inhibits translation by a calcineurin-independent mechanism (A) Immunoblot showing that knocking down calcineurin A does not block siRCAN1-4-
induced reduction of Ras. U87MG cells were co-transfected with either siRNA targeting calcineurin Aa (siCnAa) or b (siCnAb), and either siRCAN1-4 or siCon in combinations
as indicated. (B) Immunoblot showing that calcineurin inhibitors cyclosporine A (CsA; 1 lM) or FK506 (50 nM) does not block the reduced response to bFGF (10 ng/ml)
stimulation in siRCAN1-4-transfected cells. (C–E) Immunoblot showing the effects of RCAN1 knockdown (C), calcineurin A knockdown (D), or the over-expression of
calcineurin A mutants (E) on vector-mediated GFP expression. GFP transcript levels were shown by RT-PCR.
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